<DOC>
	<DOCNO>NCT00192244</DOCNO>
	<brief_summary>- The purpose study determine efficacy CAIV-T diverse Asian population age 6 month le 36 month , tropical temperate climate , culture-confirmed influenza illness . In addition , trial provide opportunity investigate efficacy CAIV-T multiple influenza season , investigate effect CAIV-T acute otitis medium .</brief_summary>
	<brief_title>Trial Determine Safety Efficacy Influenza Virus Vaccine , Trivalent , Types A &amp; B , Live , Cold-Adapted ( CAIV-T ) Healthy Children</brief_title>
	<detailed_description />
	<criteria>great equal 6 month le 36 month age time enrollment , good health determine medical history , physical examination , clinical judgment ; whose parent legal guardian provide write informed consent nature study explain ; , along parent legal guardian , available duration study ( 24 month ) ; whose parent/legal guardian reach study staff postimmunization contact [ via telephone , clinic home visit ] . whose parent caregiver perceive unreliable difficult contact evaluation study visit study period ; serious chronic disease ( e.g. , sign cardiac renal failure severe malnutrition ) , include progressive neurological disease ; Down 's syndrome know cytogenetic disorder ; know suspected disease immune system receive immunosuppressive therapy , include systemic corticosteroid ; receive blood product , include immunoglobulin , period six month prior vaccination conclusion study ; intent administer investigational vaccine agent one month prior enrollment conclusion study ; immunosuppressed compromise individual living household ; , time prior entry study , receive dose influenza vaccine ( commercial investigational ) ; administer live virus vaccine within one month prior study vaccination expect receipt another live virus within one month vaccination study ; document history hypersensitivity egg egg protein , component study vaccine placebo ; respiratory illness wheeze within two week prior enrollment ; receive aspirin ( acetylsalicylic acid ) aspirincontaining product two week prior enrollment use anticipate study ; medical condition opinion Investigator might interfere interpretation study result ; Note : A pregnant household member day care provider consider contraindication enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>35 Months</maximum_age>
	<verification_date>October 2006</verification_date>
</DOC>